HNB
NVCR icon

Huntington National Bank’s NovoCure NVCR Stock Holding History

Huntington National Bank’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-31
Closed -$1.29K – 3889
2023
Q2 		$1.29K Buy
+31
New +$1.93K ﹤0.01% 2122
2023
Q1 		– Sell
-32
Closed -$2.35K – 3663
2022
Q4 		$2.35K Buy
32
+15
+88% +$1.13K ﹤0.01% 1739
2022
Q3 		$1K Sell
17
-3
-15% -$234 ﹤0.01% 1942
2022
Q2 		$1K Buy
20
+7
+54% +$527 ﹤0.01% 1971
2022
Q1 		$1K Buy
13
+7
+117% +$516 ﹤0.01% 1980
2021
Q4 		$0 Buy
+6
New +$602 ﹤0.01% 2215

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Huntington National Bank's NVCR Position: Q3 2023 in Review

Huntington National Bank sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 31 shares — an estimated $1.29K sold.

Huntington National Bank first reported a position in NVCR in Q4 2021 and held it in 6 quarters. The position peaked at $2.35K in Q4 2022. 227 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

  • Huntington National Bank reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
  • Huntington National Bank sold 31 NovoCure shares in Q3 2023, an estimated $1.29K.
  • Huntington National Bank first reported a position in NovoCure in Q4 2021 and held it in 6 quarters.
  • Huntington National Bank's NovoCure position peaked at $2.35K in Q4 2022.
  • 227 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on Huntington National Bank's 13F filing for Q3 2023, filed 8 Nov 2023.